Annual IBA World Life Sciences Conference

Subjects include:

– Clinical trials: current trends and perspectives at a global level
– Data exclusivity/Bolar – the EU Pharma Package and other jurisdictions
– Antitrust and intellectual property – divisionals, patent settlements, unlawful PTEs and PTAs
– Preventive health and longevity: legal perspectives shaping the future of healthcare
– Cross-border intellectual property litigation
– Integration of pharma and MedTech with hospitals, clinics and pharmacies
– Liability and accountability in open science research
– Combination products (drug-device) regulation: emerging legal complexities
– Preparing for the entry into force of the WIPO GRATK Treaty
– Artificial intelligence and biotechnology: rethinking patent standards
– AI and data rights in life sciences and HealthTech deals (training data, model outputs and infringement risk)
– Collaboration and licensing structures as financing tools
– Life sciences M and A in uncertain markets – earnouts, contingent value rights, contingent milestones and intellectual property-driven valuation mechanics
– Late-stage private financings and IPO alternatives (crossovers, structured preferred, PIPEs, ATMs, registered directs)
– Cross-border investment constraints affecting financings and exits (CFIUS risk, sensitive health/genomic data and closing conditions)
URLs:
Tickets: https://go.evvnt.com/3479886-0?pid=10008Website: https://go.evvnt.com/3479886-2?pid=10008Sponsor: https://go.evvnt.com/3479886-3?pid=10008Prices:
IBA Member: EUR 1305.00,
Non-member: EUR 1520.00,
Young lawyers (under 30 years): EUR 1520.00,
Academics / judges (full-time): EUR 1520.00,
Public lawyers: EUR 1520.00,
Corporate Counsel: EUR 1520.00
Category: Conferences | Business and Economics | Legal
Date and Time: 3rd June 2026 at 9:00 am to 5th June 2026 at 5:00 pm